Core Viewpoint - Inspire Medical Systems (INSP) is expected to report a quarterly earnings per share (EPS) of 197.65 million, a 28.9% increase compared to the same quarter last year [1]. Earnings Estimates - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not reassessed their initial estimates during this period [2]. - Revisions to earnings projections are crucial for predicting investor behavior regarding the stock, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue Projections - Analysts estimate that 'Geographic Revenue - United States' will reach 6.68 million, indicating a year-over-year increase of 15.5% [5]. Medical Centers and Sales Territories - Analysts predict that 'New U.S. Medical Centers' will total 53, down from 62 in the previous year [5]. - The total number of 'U.S. Medical Centers' is expected to reach 1,369, up from 1,107 in the same quarter last year [6]. - 'New U.S. sales territories' are projected to remain at 13, while 'Total U.S. sales territories' are expected to increase to 323 from 274 year-over-year [6]. Stock Performance - Shares of Inspire have decreased by 4.9% over the past month, contrasting with a 1.8% increase in the Zacks S&P 500 composite [7]. - With a Zacks Rank of 2 (Buy), INSP is anticipated to outperform the overall market in the near future [7].
Seeking Clues to Inspire (INSP) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics